Health
Farmaceutica Remedia Aims For 20% Growth In 2012
Pharmaceuticals distributor Farmaceutica Remedia (RMAH.RO), controlled by businessman Valentin Tarus, budgeted revenues of about EUR60 million for 2012, up 20% on the year.
Synevo Labs Sees Sales Up To EUR27M In 2012
Synevo Romania, the local medical lab division of Swedish group Medicover, estimates it will post a turnover of EUR27 million this year, up 17% against 2011.
Health Ministry To Begin Talks On New Health Bill Thursday, With Doctors' College
Romania's Health Ministry will begin discussions Thursday to develop a new healthcare bill and revise the basic service package, with the Doctors' College being the first partner invited for...
Romanian President Says Health Reform Is Top Priority This Year
Romanian President Traian Basescu told diplomats Thursday that completing the law reforming the country’s healthcare system is a top priority for this year.
What Model Should Romania Choose For Its Healthcare Reform?
The healthcare reform is now at its second attempt considering the first consultations with the Association of Family Practioners in Bucharest, the Association for Patient Protection and the...
Anima Specialty Medical Services Takes Over Diagnosis Clinics
Romanian private healthcare provider Anima Specialty Medical Services took over a 70% stake in the Diagnosis clinics, previously owned by investment fund Gemisa.
Raed Arafat Rejoins Romanian Health Ministry
Dr. Raed Arafat, who resigned from the position of Health Ministry deputy secretary of state last week, will return to the ministry to fill the same position, Romanian Prime Minister Emil Bo...
A&D Pharma Buys Diagnosis, Its First Clinic Acquisition
A&D Pharma, the largest group in the Romanian pharmaceutical industry has bought 80% in the two Diagnosis clinics, extending its private healthcare network to eight units.
EUR6B Dissipated Each Year In Healthcare System
The tensions generated by the reform of the health system reached maximum highs, with people taking to the streets, but there is still a need to clarify the lack of transparency in the spend...